Previous close | 14.47 |
Open | 14.47 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 14.47 - 14.47 |
52-week range | 14.47 - 20.28 |
Volume | |
Avg. volume | 482 |
Market cap | 6.943B |
Beta (5Y monthly) | 0.18 |
PE ratio (TTM) | 8.51 |
EPS (TTM) | 1.70 |
Earnings date | N/A |
Forward dividend & yield | 0.53 (3.65%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
Q4 2023 Cue Biopharma Inc Earnings Call
Advancements in Clinical Trials and Strong Cash Position Highlighted
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that in order to accelerate the open innovation, it has increased its investment pool from US$100 million to US$200 million to continue strategic investment in Ono Venture Investment Fund I, L.P. ("OVI FI"), which was established as a corporate venture capital fund in CA, USA in May 2020.